Cardiac Allograft Vasculopathy: A Focus on Advances in Diagnosis and Management

Area of Science:

• Cardiovascular Medicine
• Transplantation Immunology
• Medical Imaging

Background:

• Cardiac allograft vasculopathy (CAV) is a specific form of coronary artery disease affecting heart transplant recipients.
• It represents a major cause of long-term morbidity and mortality post-transplantation, often linked to chronic rejection.
• Both immune and nonimmune factors drive CAV, leading to intimal thickening, fibrosis, and graft failure.

Purpose of the Study:

• To highlight the significance of cardiac allograft vasculopathy (CAV) in heart transplantation.
• To discuss the role of recent imaging advancements in the early detection of CAV.
• To explore the potential of improved detection for optimizing CAV-targeted therapies and preserving graft function.

Main Methods:

• Review of recent advances in imaging modalities for CAV detection.
• Inclusion of both invasive intracoronary imaging techniques.
• Inclusion of noninvasive imaging, specifically cardiac positron emission tomography.

Main Results:

• Advanced imaging modalities have enhanced the early detection capabilities for CAV.
• These improved detection methods offer potential for timely intervention.
• Optimized therapies guided by early detection may reduce CAV progression.

Conclusions:

• Early detection of CAV through advanced imaging is crucial for heart transplant recipients.
• Optimizing CAV-targeted therapies based on early detection can improve outcomes.
• Preserving graft function and reducing long-term mortality are key goals in managing CAV.